Page 101 - CIBERES-2015-eng

Most relevant scientific articles
Research Groups
sánChez-De-La-torre M., KhaLyFa a., sánChez-De-La- torre a., Martínez-aLonso M., Martínez-garCía M.a., BarCeLo a. et aL. Precision Medicine in Patients With Re- sistant Hypertension and Obstructive Sleep Apnea Blood Pressure Response to Continuous Positive Airway Pres- sure Treatment. Journal of the American College of Cardi- ology. 2015;66(9):1023-1032.
sánChez-De-La-torre M., naDaL n., CortiJo a., Masa J.F., Duran-CantoLLa J., vaLLs J. et aL. Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: A randomised controlled tri- al. Thorax. 2015;70(4):346-352.
BarBé F, sánChez-De-La-torre a, aBaD J, Durán-Can- toLLa J, MeDiano o, aMiLiBia J et aL. Effect of obstruc-
Highlights
Group 35 of the Centre for Biomedical Network Re- search on Respiratory Diseases (CIBER) is led by Dr. Ferran Barbé. Group 35 focuses its research on the study of the Sleep Apnea Syndrome (OSAS). In 2015 Group 35 was responsible for 32 original pub- lications. It also received funding for competitive development for 14 new research projects calls and started participating in 4 new clinical trials. These projects aim to understand the underlying causes of the pathological manifestation associated with SAHS, and the development and adaptation of treat- ments for patients with this pathology. It has also developed the first international patent for identify-
tive sleep apnoea on severity and short-term prognosis of acute coronary syndrome.The European respiratory jour- nal. 2015;45(2):419-27.
Masa J.F., CorraL J., aLonso M.L., orDax e., tronCoso M.F., gonzáLez M. et aL. Efficacy of different treatment al- ternatives for obesity hypoventilation syndrome: Pickwick study. American Journal of Respiratory and Critical Care Medicine. 2015;192(1):86-95.
soriano J.B., LaMPreCht B., raMírez a.s., Martínez-CaM- BLor P., Kaiser B., aLFageMe i. et aL. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: A pooled analysis of individual patient data. The Lancet Respiratory Medi- cine. 2015;3(6):443-450.
ing, through predictive measures and by analyzing microRNAs in plasma, if a patient with resistant hy- pertension and OSA will respond to treatment with CPAP which, in turn, lowers their blood pressure . They have also participated in the development of several transfer contract of a specific device for the diagnosis of OSA, and form part of a new spin-off as well. Moreover, Group 35 is responsible for develop- ing clinical guidelines for the control and monitoring of respiratory therapies in Spain. Last but not least, two awards have been received and the group has been invited to participate in more than 20 interna- tional and national conferences.
Institution: Instituto de Investigación Biomédica de Lleida. Fundación Dr. Pifarré
Contact: Avda. Alcalde Rovira Roure, 80.25198 Lleida · Tel.: 973 705 372 · E.mail: [email protected] Web: http://www.ciberes.org/index.php?option=com_personal&view=personal&Group_id=35&Itemid=77
CIBERES I Annual report 2015 I 101